Wavelength-specific cytotoxic agents
    6.
    发明授权
    Wavelength-specific cytotoxic agents 失效
    波长特异性细胞毒性剂

    公开(公告)号:US5171749A

    公开(公告)日:1992-12-15

    申请号:US718393

    申请日:1991-06-20

    摘要: A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation for therapy to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.

    摘要翻译: 具有吸收最大值在670-780纳米范围内的一组氢 - 单苯并卟啉“绿色卟啉”(Gp)可用于治疗在光存在下经受血卟啉衍生物(HPD)治疗的病症或病症,或治疗 病毒,细胞和组织通常会破坏不想要的靶。 使用本发明的Gp允许用于治疗的照射使用除了被血液吸收的波长以外的波长。 本发明的Gp还可以与受体特异性配体或特异性免疫球蛋白或其片段缀合以靶向用于放射治疗的特定组织或细胞。 使用这些材料允许使用较低水平的药物,从而防止可能破坏正常组织的副反应。

    Wavelength-specific cytotoxic agents
    7.
    发明授权
    Wavelength-specific cytotoxic agents 失效
    波长特异性细胞毒素

    公开(公告)号:US5095030A

    公开(公告)日:1992-03-10

    申请号:US414201

    申请日:1989-09-28

    摘要: A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.

    摘要翻译: 具有吸收最大值在670-780纳米范围内的一组氢 - 单苯并卟啉“绿色卟啉”(Gp)可用于治疗在光存在下经受血卟啉衍生物(HPD)治疗的病症或病症,或治疗 病毒,细胞和组织通常会破坏不想要的靶。 本发明的Gp的使用允许照射使用除血液吸收的波长以外的波长。 本发明的Gp还可以与受体特异性配体或特异性免疫球蛋白或其片段缀合以靶向用于放射治疗的特定组织或细胞。 使用这些材料允许使用较低水平的药物,从而防止可能破坏正常组织的副反应。

    Method of treating skin diseases
    8.
    发明授权
    Method of treating skin diseases 失效
    治疗皮肤病的方法

    公开(公告)号:US5399583A

    公开(公告)日:1995-03-21

    申请号:US187307

    申请日:1994-01-25

    摘要: A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation for therapy to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.

    摘要翻译: 具有吸收最大值在670-780纳米范围内的一组氢 - 单苯并卟啉“绿色卟啉”(Gp)可用于治疗在光存在下经受血卟啉衍生物(HPD)治疗的病症或病症,或治疗 病毒,细胞和组织通常会破坏不想要的靶。 使用本发明的Gp允许用于治疗的照射使用除了被血液吸收的波长以外的波长。 本发明的Gp还可以与受体特异性配体或特异性免疫球蛋白或其片段缀合以靶向用于放射治疗的特定组织或细胞。 使用这些材料允许使用较低水平的药物,从而防止可能破坏正常组织的副反应。

    Wavelength-specific cytotoxic agents
    9.
    发明授权
    Wavelength-specific cytotoxic agents 失效
    波长特异性细胞毒性剂

    公开(公告)号:US5283255A

    公开(公告)日:1994-02-01

    申请号:US943895

    申请日:1992-09-11

    摘要: A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation for therapy to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.

    摘要翻译: 具有吸收最大值在670-780纳米范围内的一组氢 - 单苯并卟啉“绿色卟啉”(Gp)可用于治疗在光存在下经受血卟啉衍生物(HPD)治疗的病症或病症,或治疗 病毒,细胞和组织通常会破坏不想要的靶。 使用本发明的Gp允许用于治疗的照射使用除了被血液吸收的波长以外的波长。 本发明的Gp还可以与受体特异性配体或特异性免疫球蛋白或其片段缀合以靶向用于放射治疗的特定组织或细胞。 使用这些材料允许使用较低水平的药物,从而防止可能破坏正常组织的副反应。

    Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
    10.
    发明授权
    Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents 失效
    水 - 单苯并卟啉波长特异性细胞毒素

    公开(公告)号:US4920143A

    公开(公告)日:1990-04-24

    申请号:US221161

    申请日:1988-07-19

    摘要: A group of hydro-monobenzoporphyrins "green porphyrins" (Gp) having absorption maxima in the range of 670-780 nanometers is useful in treating disorders or conditions which are subject to hematoporphyrin derivative (HPD) treatment in the presence of light, or in treating virus, cells and tissues generally to destroy unwanted targets. The use of the Gp of the invention permits the irradiation to use wavelengths other than those absorbed by blood. The Gp of the invention may also be conjugated to ligands specific for receptor or to specific immunoglobulins or fragments thereof to target specific tissues or cells for the radiation treatment. Use of these materials permits lower levels of drug to be used, thus preventing side reactions which might destroy normal tissues.

    摘要翻译: 具有吸收最大值在670-780纳米范围内的一组氢 - 单苯并卟啉“绿色卟啉”(Gp)可用于治疗在光存在下经受血卟啉衍生物(HPD)治疗的病症或病症,或治疗 病毒,细胞和组织通常会破坏不想要的靶。 本发明的Gp的使用允许照射使用除血液吸收的波长以外的波长。 本发明的Gp还可以与受体特异性配体或特异性免疫球蛋白或其片段缀合以靶向用于放射治疗的特定组织或细胞。 使用这些材料允许使用较低水平的药物,从而防止可能破坏正常组织的副反应。